30 results  1 of 2 

1 Significance of tumor-associated neutrophils, lymphocytes, and neutrophil-to-lymphocyte ratio in non-invasive and invasive bladder urothelial carcinoma
Wael Abdo Hassan, Ahmed Kamal ElBanna, Noha Noufal, Mohamed El-Assmy, Hany Lotfy, Rehab Ibrahim Ali
J Pathol Transl Med.2023;57(2):88-94.   Published online 2023 January 10     DOI: http://dx.doi.org/10.4132/jptm.2022.11.06
      
2 Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
Hongsik Kim, Byong Chang Jeong, Joohyun Hong, Ghee Young Kwon, Chan Kyo Kim, Won Park, Hongryull Pyo, Wan Song, Hyun Hwan Sung, Jung Yong Hong, Se Hoon Park
Cancer Res Treat.2023;55(2):636-642.   Published online 2022 October 6     DOI: http://dx.doi.org/10.4143/crt.2022.343
      
3 Clinically undetected plasmacytoid urothelial carcinoma of the urinary bladder with non-mass-forming metastases in multiple organs: an autopsy case
Yuya Asano, Kosuke Miyai, Shinya Yoshimatsu, Makoto Sasaki, Katsunori Ikewaki, Susumu Matsukuma
J Pathol Transl Med.2022;56(4):217-224.   Published online 2022 May 3     DOI: http://dx.doi.org/10.4132/jptm.2022.03.15
      
4 Clinical Characteristics, Treatment Delivery, and Cisplatin Eligibility in Korean Patients Initially Diagnosed with Urothelial Carcinoma
Kwonoh Park, Jong Kil Nam, Bon Jin Koo, Hyun Jung Lee, Tae Un Kim, Hwaseong Ryu, Yun Jeong Hong, Seungsoo Lee, Dong Hoon Lee, Sung Woo Park
Ewha Med J.2021;44(3):63-69.   Published online 2021 July 31     DOI: http://dx.doi.org/10.12771/emj.2021.44.3.63
      
5 Distinctive morphological and molecular features of urothelial carcinoma with an inverted growth pattern
Francesca Sanguedolce, Beppe Calò, Marco Chirico, Ugo Falagario, Gian Maria Busetto, Magda Zanelli, Alessandra Bisagni, Maurizio Zizzo, Stefano Ascani, Giuseppe Carrieri, Luigi Cormio
J Pathol Transl Med.2021;55(4):239-246.   Published online 2021 June 14     DOI: http://dx.doi.org/10.4132/jptm.2021.04.20
      
6 Sarcomatoid urothelial carcinoma arising in the female urethral diverticulum
Heae Surng Park
J Pathol Transl Med.2021;55(4):298-302.   Published online 2021 June 1     DOI: http://dx.doi.org/10.4132/jptm.2021.04.23
      
7 Programmed cell death-ligand 1 assessment in urothelial carcinoma: prospect and limitation
Kyu Sang Lee, Gheeyoung Choe
J Pathol Transl Med.2021;55(3):163-170.   Published online 2021 April 7     DOI: http://dx.doi.org/10.4132/jptm.2021.02.22
      
8 Use of Gemcitabine Plus Carboplatin Is Associated with Poor Outcomes in Urothelial Carcinoma Patients with Chronic Kidney Disease Stage 4–5
Hyung-Don Kim, Hyeon-Su Im, Jwa Hoon Kim, Hyehyun Jeong, Shin Kyo Yoon, Inkeun Park, Jae Lyun Lee
Cancer Res Treat.2021;53(4):1166-1173.   Published online 2021 March 4     DOI: http://dx.doi.org/10.4143/crt.2021.091
      
9 Effects of Complete Bladder Cuff Removal on Oncological Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
Hyunsoo Ryoo, Jungyu Kim, Taejin Kim, Minyong Kang, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, Hyun Hwan Sung
Cancer Res Treat.2021;53(3):795-802.   Published online 2020 December 28     DOI: http://dx.doi.org/10.4143/crt.2020.919
      
10 Histologically confirmed distant metastatic urothelial carcinoma from the urinary bladder: a retrospective review of one institution’s 20-year experience
Youngeun Yoo, Junghye Lee, Heae Surng Park, Min-Sun Cho, Sun Hee Sung, Sanghui Park, Euno Choi
J Pathol Transl Med.2021;55(2):94-101.   Published online 2020 December 3     DOI: http://dx.doi.org/10.4132/jptm.2020.10.19
      
11 Double cocktail immunostains with high molecular weight cytokeratin and GATA-3: useful stain to discriminate in situ involvement of prostatic ducts or acini from stromal invasion by urothelial carcinoma in the prostate
Junghye Lee, Youngeun Yoo, Sanghui Park, Min-Sun Cho, Sun Hee Sung, Jae Y. Ro
J Pathol Transl Med.2020;54(2):146-153.   Published online 2020 February 10     DOI: http://dx.doi.org/10.4132/jptm.2019.11.12
      
12 Atezolizumab in Patients with Pretreated Urothelial Cancer: a Korean Single-Center, Retrospective Study
Joon Young Hur, Youjin Kim, Ghee-Young Kwon, Minyong Kang, Hyun Hwan Sung, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, Su Jin Lee, Se Hoon Park
Cancer Res Treat.2019;51(4):1269-1274.   Published online 2019 January 9     DOI: http://dx.doi.org/10.4143/crt.2018.604
      
13 Laparoscopy versus Open Nephroureterectomy in Prognostic Outcome of Patients with Advanced Upper Tract Urothelial Cancer: A Retrospective, Multicenter, Propensity-Score Matching Analysis
Sung Han Kim, Mi Kyung Song, Jung Kwon Kim, Bumsik Hong, Seok Ho Kang, Ja Hyeon Ku, Byong Chang Jeong, Ho Kyung Seo
Cancer Res Treat.2019;51(3):963-972.   Published online 2018 October 12     DOI: http://dx.doi.org/10.4143/crt.2018.465
      
14 Oncologic Outcomes and Predictive Factors for Recurrence Following Robot-Assisted Radical Cystectomy for Urothelial Carcinoma: Multicenter Study from Korea
Ji Sung Shim, Tae Gyun Kwon, Koon Ho Rha, Young Goo Lee, Ji Youl Lee, Byong Chang Jeong, Jae Yoon Kim, Jong Hyun Pyun, Sung Gu Kang, Seok Ho Kang
J Korean Med Sci.2017;32(10):1662-1668.   Published online 2017 August 14     DOI: http://dx.doi.org/10.3346/jkms.2017.32.10.1662
      
15 Impact of the ASA Physical Status Score on Adjuvant Chemotherapy Eligibility and Survival of Upper Tract Urothelial Carcinoma Patients: a Multicenter Study
Ho Won Kang, Sung Pil Seo, Won Tae Kim, Yong-June Kim, Seok Joong Yun, Sang-Cheol Lee, Young Deuk Choi, Yun-Sok Ha, Tae-Hwan Kim, Tae Gyun Kwon, Seok-Soo Byun, Seong Uk Jeh, Wun-Jae Kim
J Korean Med Sci.2017;32(2):335-342.   Published online 2016 December 12     DOI: http://dx.doi.org/10.3346/jkms.2017.32.2.335
      
16 Comparison of the FDA and ASCO/CAP Criteria for HER2 Immunohistochemistry in Upper Urinary Tract Urothelial Carcinoma
Gilhyang Kim, Yul Ri Chung, Bohyun Kim, Boram Song, Kyung Chul Moon
J Pathol Transl Med.2016;50(6):436-441.   Published online 2016 October 10     DOI: http://dx.doi.org/10.4132/jptm.2016.07.12
      
17 Differential Immunohistochemical Profiles for Distinguishing Prostate Carcinoma and Urothelial Carcinoma
Woo Jin Oh, Arthur Minwoo Chung, Jee Soon Kim, Ji Heun Han, Sung Hoo Hong, Ji Yeol Lee, Yeong Jin Choi
J Pathol Transl Med.2016;50(5):345-354.   Published online 2016 August 7     DOI: http://dx.doi.org/10.4132/jptm.2016.06.14
      
18 Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer
Vivek Narayan, Ronac Mamtani, Stephen Keefe, Thomas Guzzo, S. Bruce Malkowicz, David J. Vaughn
Cancer Res Treat.2016;48(3):1084-1091.   Published online 2015 December 2     DOI: http://dx.doi.org/10.4143/crt.2015.405
      
19 Parafibromin Staining Characteristics in Urothelial Carcinomas and Relationship with Prognostic Parameters
Serap Karaarslan, Banu Yaman, Hakan Ozturk, Banu Sarsik Kumbaraci
J Pathol Transl Med.2015;49(5):389-395.   Published online 2015 September 15     DOI: http://dx.doi.org/10.4132/jptm.2015.08.10
      
20 The Characteristics of Recurrent Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy without Bladder Cuff Excision
Minyong Kang, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim, Ja Hyeon Ku
Yonsei Med J.2015;56(2):375-381.   Published online 2015 February 9     DOI: http://dx.doi.org/10.3349/ymj.2015.56.2.375
      

 1 of 2